KIRCALİ, E. Et Al. 2022. Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome. 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) , (United States Of America).

KIRCALİ, E., CENGİZ SEVAL, G., CİVRİZ BOZDAĞ, S., YÜKSEL, M., TOPÇUOĞLU, P., ARSLAN, Ö., ... ÖZCAN, M.(2022). Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome . 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), United States Of America

KIRCALİ, EKİN Et Al. "Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome," 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), United States Of America, 2022

KIRCALİ, EKİN Et Al. "Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome." 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) , United States Of America, 2022

KIRCALİ, E. Et Al. (2022) . "Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome." 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) , United States Of America.

@conferencepaper{conferencepaper, author={EKİN KIRCALİ Et Al. }, title={Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome}, congress name={48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)}, city={}, country={United States Of America}, year={2022}}